ArticleTargeted oncology2023

Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours.

Chih-Chieh Yen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.